このエントリーをはてなブックマークに追加
ID 53542
Sort Key
14
Title Alternative
Proton therapy
FullText URL
Thumnail 127_155.pdf 310 KB
Author
Okimoto, Tomoaki
Note
キーワード(Key Word)
Publication Title
岡山医学会雑誌
Published Date
2015-08-03
Volume
volume127
Issue
issue2
Publisher
岡山医学会
Publisher Alternative
Okayama Medical Association
Start Page
155
End Page
157
ISSN
0030-1558
NCID
AN00032489
Content Type
Article
Related Url
isVersionOf https://doi.org/10.4044/joma.127.155
OAI-PMH Set
岡山大学
language
日本語
Copyright Holders
Copyright (c) 2015 岡山医学会
File Version
publisher
Refereed
True
DOI
NAID
Eprints Journal Name
joma
References
1) Demizu Y, Fujii O, Terashima K, Mima M, Hashimoto N, Niwa Y, Akagi T, Daimon T, Murakami M, Fuwa N : Particle therapy for mucosal melanoma of the head and neck. A single-institution retrospective comparison of proton and carbon ion therapy. Strahlenther Onkol (2014) 190, 186-191.
2) Komatsu S, Fukumoto T, Demizu Y, Miyawaki D, Terashima K, Sasaki R, Hori Y, Hishikawa Y, Ku Y, Murakami M : Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma. Cancer (2011) 117, 4890-4904.
3) Miralbell R, Lomax A, Cella L, Schneider U : Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys (2002) 54, 824-829.
4) Merchant TE, Kiehna EN, Li C, Shukla H, Sengupta S, Xiong X, Gajjar A, Mulhern RK : Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma. Int J Radiat Oncol Biol Phys (2006) 65, 210-221.
5) Hoppe BS, Flampouri S, Zaiden R, Slayton W, Sandler E, Ozdemir S, Dang NH, Lynch JW, Li Z, Morris CG, Mendenhall NP : Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma : results of a phase 2 study. Int J Radiat Oncol Biol Phys (2014) 89, 1053-1059.
6) Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, Mohan R, Komaki R, Cox JD : Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2006) 65, 1087-1096.
7) Chang JY, Komaki R, Lu C, Wen HY, Allen PK, Tsao A, Gillin M, Mohan R, Cox JD : Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer. Cancer (2011) 117, 4707-4013.